Lee Roy Morgan
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2016First federal award
$1.7MFederal grants as PI8 awards
2Patents grantedLatest Sep 15, 2020
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
8 awards · $1.7M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Feb 19, 2020 | NIH | SBIR Phase II 4-Demethyl-4-cholesteryloxycarbonylpenclomedine (DM-CHOC-PEN: A Phase II Clinical Trial in Adolescents/Young Adults (AYA)with CNS Malignancies | $451K | DEKK-TEC, INC. |
| Feb 27, 2019 | NIH | SBIR Phase II 4-Demethyl-4-cholesteryloxycarbonylpenclomedine (DM-CHOC-PEN: A Phase II Clinical Trial in Adolescents/Young Adults (AYA)with CNS Malignancies | $519K | DEKK-TEC, INC. |
| Sep 24, 2018 | NIH | SBIR Phase II 4-Demethyl-4-cholesteryloxycarbonylpenclomedine (DM-CHOC-PEN: A Phase II Clinical Trial in Adolescents/Young Adults (AYA)with CNS Malignancies | $240K | DEKK-TEC, INC. |
| Jan 18, 2018 | NIH | SBIR Phase I A Phase I Clinical Trial: Binary Therapy with DM-CHOC-PEN and WBRT in Adults with Cancer Involving the CNS | $143K | DEKK-TEC, INC. |
| Feb 3, 2017 | NIH | SBIR Phase I A Phase I Clinical Trial: Binary Therapy with DM-CHOC-PEN and WBRT in Adults with Cancer Involving the CNS | $143K | DEKK-TEC, INC. |
| Jan 31, 2017 | NIH | SBIR Phase I Phase I Clinical trial with 4-Demethyl-4-cholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) in Children with Cancer Involving the CNS | $90K | DEKK-TEC, INC. |
| Jan 13, 2017 | NIH | SBIR Phase I The DEKK-TEC I-Corp Team | $50K | DEKK-TEC, INC. |
| Jan 5, 2016 | NIH | SBIR Phase I Phase I Clinical trial with 4-Demethyl-4-cholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) in Children with Cancer Involving the CNS | $90K | DEKK-TEC, INC. |
3 patents as inventor
- US 10772878DEKK-TEC, INC.Sep 15, 2020
- US 9884051DEKK-TEC, INC.Feb 6, 2018
- US DEKK-TEC, INC.—
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#1,221
Awards as PI#190
Patents#102
Companies
- DEKK-TEC, INC.Linked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.